Form4insider filings, from the source

SEC Form 4 · accession 0001209191-18-021679

Armata Pharmaceuticals, Inc. · ARMP

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Period of report
Jun 29, 2017
Accepted (ET)
Mar 26, 2018 · 8:51 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000921114

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1,F2,F3Jun 29, 2017P$05,757—A124,270ISee Footnote
Common StockF1,F3Sep 19, 2017P$0105,015—A229,285ISee Footnote
Common StockF3Mar 22, 2018P181,820$1.10A411,105ISee Footnote
Common Stockholding———230D

Table II — derivative securities

No Table II lines on this filing.

Explanation of responses